Category Archives: Health Care

Innovacare Health Adds Three Leadership Positions To Its Management

InnovaCare Health is a healthcare organization that deals with managed healthcare. Coincidentally, managed healthcare is prevalent in America’s healthcare insurance plan. Being an organization that deals with sensitive issues regarding health, InnovaCare Health is very specific with the leaders it has elected. That is why the board of directors was glad to announce the three additional leaders in the team. Through the leadership of these three individuals, InnovaCare Health is set to prosper in its quest to provide the best-managed healthcare services.


Background Data


Richard A. Shinto is the chief executive officer of InnovaCare Health. He is also the head of InnovaCare Health Solutions. In his capacity as a team leader, Shinto has worked hard to establish a friendly relationship between InnovaCare Health and its clients. Most fundamentally, he has been walking the company through a rapidly growing platform that embraces healthcare.


Shinto’s Experience


However, before joining InnovaCare Health, Rick Shinto worked as a senior executive in many companies including PMC Medicare Choice, MMM Healthcare Inc, NAMM California, Med Partners of Medical Pathways Management and Aveta in North America. In all these companies, Dr Shinto was a senior executive. Therefore, it is natural for him to exude the level confidence that he has been oozing at InnovaCare Health. For education, Shinto graduated from Stony Brook State University in New York.


Penelope’s Contribution


Next in line is Penelope Kokkinides. Penelope Kokkinides is an outstanding leader as well as an experienced manager in handling managed healthcare. A graduate of New York University and the prestigious Binghamton University, Penelope Kokkinides has mastered her roles in leadership. Her mission, she says in an interview with Idea Mensch, is to provide competent managed healthcare that will always leave patients satisfied with InnovaCare Health’s services.


Additional Information


Before she joined InnovaCare Health, Kokkinides worked in different healthcare companies including Touchstone Health, AmeriChoice and Centerlight Healthcare. In all these companies, she was a senior executive, and her roles included overseeing overall management. Coupled with her extensive knowledge as well as expertise in inventing clinical programs, Penelope Kokkinides has vast experience in managed healthcare. She applies this wealth of knowledge on improving healthcare. That is why since she joined InnovaCare Health, even the customer service department has developed its ability to serve patients. See This Page for additional information.


The Overview


Moreover, Penelope Kokkinides has aggressively created a safe landing for patients with all types of health problems including terminal illnesses.




Rick Shinto And Penelope Kokkinides Are Having a Major Impact In The Healthcare Industry

Innovacare Health is one of the leaders in healthcare managing in the United States, contributing to the mental and emotional well-being of seniors, equipped with 5001-10000 employees. There a wide-range of complexities within healthcare management, and the key to their success has a lot to do with the influence of Penelope Kokkinides, and Chief Executive Officer Rick Shinto. When it comes to the fields of managing in healthcare, Penelope Kokkinides has over 20 years being an expert, with experience in handling Medicare and Medicaid.


There are many well-known organizations that she has had the opportunity to work for, such as, Touchstone Health, Centerlight Healthcare, and AmeriChoice, which assisted her in establishing a prestigious track record. With Penelope Kokkinides and Rick Shinto working hand in hand, they have been able to transform many aspects of healthcare management with innovative programs with Innovacare Health.


The cost of seeing a doctor these days can be very expensive and utilizing the HealthCare Payment and Learning Action Network at Innovacare, this makes it more affordable for patients to get treatment from a physician, which was started by the U.S. Department of Health and Human Services. This program has enabled Rick Shinto and Penelope Kokkinides serve even more clients, being the lead provider in not only the United States, but Puerto Rico as well, with their Medicare Advantage plans, and Provider Networks, the two primary avenues of care.


Currently, Innovacare has over 200,000 members who utilizes their revolutionary programs, with them being so cost-effective, meeting their medical needs, redefining healthcare management. The goal of Rick Shinto and Penelope Kokkinides, is to provide the best possible medical care, focusing on keep building relationships between the patient and the physician. InnovaCare Health’s mission is to keep the patient first in mind, while providing their high-quality medical practices.


What Penelope and Rick Shinto brings to Innovacare is leadership, understanding each person’s vision regardless of the tough challenges that managing healthcare experiences. With their highly educated staff at Innovacare, as a team they have been able to have a major impact withing the healthcare management industry today. Read This Article to learn more.


Check out the company’s profile on

Mikhail Blagosklonny, the Human Life Preserver

One of the world’s top oncologist, at 56, Mikhail Blagosklonny, a Russian scientist wears many hats and accomplishments and will leave this world with a hugh mark in the medical field and on the students he teaches. Some of his accomplishments includes: 270+ papers, senior scientist at the Ordway Research Institute in New York, editor-in chief of three publications, “Oncotarget’, “Cell Cycle” and “Aging”. He also is the founder of “Cell Cycle” publication. Other accomplishes are: associate professor of Medicine at New York Medical College, also in New York, an associate editor of the journal “Cancer Biology and Therapy”, on the editorial board of “Cell Death and Differentiation, and has an H-index of 83. As a teach he brings inspiration to hundreds of future doctors, researchers, and scientist.

Blagosklonny graduated from First Pavlov State Medical University of St Petersburg and there he received a M.D. in internal medicine and a PhD in experimental medicine and cardiology. In 2009 he started teaching as a professor of oncology at Roswell Park Cancer Institute were he currently performing his research today and more information click here.

One of the legacy Blagosklonny will leave behind is his fight for a cancer drug known in the medical industry called Rapamycin, which is in his and many others fellow researchers’ opinion, a drug that will prolong life., according to his research on biogerontology. He believes TOR, (Target of Rapamycin) signaling in aging and cancer will benefit using the drug and what Mikhail knows.

As an oncologist, Blagosklonny will continue his research on aging and cancer to aid the human population live without the fear of aging and cancer. He will focus on older adults and why they are more acceptable to cancer then the younger generation. Also, he wants to treat cancer in a more passive and economical way so not to burden patients with either stress factors. Today’s treatment robs the body of cells that help a patient recover, but he is forging on to find a way to destroy the cancer without such damage and Makhail’s lacrosse camp.

Until recently, aging was believed it was caused by increasing, passive damaging of cell molecules. But Blagosklonny’s clinical investigations in molecular and cellular biology led him to the theory that when the aging process is slowed down, calorie restriction and rapamycin can delay all age -related diseases like cancer. Rapamycin also can be used to prevent diseases, when given in correct dosages and learn more about Mikhail.

More Visit:


Mikhail Blagosklonny The Greatest Medical And Oncological Researcher

Mikhail Blagosklonny a renown philanthropist, a professor, a researcher and ordinary individual whose main interest is in ensuring that individuals globally get access to the best possible medical treatment regardless of their standing economically. His interest is in medical research field and he focuses mainly on studying aging and cancer. He studied at the First Pavlov State Medical University of St Petersburg where he acquired an M.D. in Internal Medicine and advanced his in academics and graduated too with a PhD in Experimental Medicine and Cardiology.

Mikhail Blagosklonny is a hardworking individual who has worked his way up the various ranks to the current his position. Currently at the Roswell Park Cancer Institute, he serves as the professor of oncology which he was appointed as from 15th April the year 2009. Previously before his appointment to this great position, he has served as the in various institutions such as the New York Medical College that is located at Valhalla in the New York as an Associate Professor of Medicine as well as the Ordway Research Institute which is situated in Albany also in the New York as a Senior Scientist. Currently at Oncotarget he is servers as the Editor-in Chief. He is also a Board Member of Cell Death and Differentiation journal. In this same journal he plays the role of being the Associate Editor of Cancer Biology and Therapy. At the cell cycle journal, Mikhail Blagosklonny doubles the role of being both the Editor-in Chief as well as the Founder Editor amd what Mikhail knows.

He is well known for advocating for the consistent use of Rapamycin Cancer drugs for purposes of possibly lengthening life span. He has conducted a number of research based on Bio gerontology which is basically concerned with the aging mechanisms and he come up with a proposal on anti-aging drug which is Rapamycin for purposes of elongating life. He has also researched on Cancer and the various therapies targeting cancer. Mikhail Blagosklonny has published more than 270 papers under his name and he still continues to write even more hitherto papers. He is well renowned for holding an h-index of 83 basically for using over 25,000 citations in his papers. Because of his great achievements in the field of Medicine and Oncology, Mikhail Blagosklonny is viewed as a scientist, physician and as a professor too and more information click here.

Mikhail Blagosklonny’s interest in studying cancer and aging is triggered by the fact that cancer I usually common to individuals older than certain age. His research work has been and will always continue to be of great help to the field of oncology. To his peer students who would want to research more on his research work in the near future, he is not only a researcher and an influential individual but a professor and an inspirational expert in his field of work. His interest is not just in cancer treatment only but in effective cancer treatment that is not excruciating and cheaper than the current cancer treatments. He hopes to come up with the best way possible of eliminating cancerous cells without destruction of the normal cells that are crucial specifically for recovery within the body after the treatment period and Mikhail’s lacrosse camp.

More visit: